Humanized-VHH Transbodies that Inhibit HCV Proteaseand Replication

Viruses

Potjanee Srimanote¹  Surasak Jittavisutthikul²  Aijaz Ahmad Malik²  Kanyarat Thueng-in³  Wanpen Chaicumpa³  Jeeraphong Thanongsaksrikul³  Monrat Chulanetra³  Watee Seesuay³ 

[1] Graduate Program in Biomedical Science, Faculty of Allied Health Sciences,Thammasat University, Pathum-thani 12120, Thailand;Graduate Program in Immunology, Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand;Laboratory for Research and Technology Development, Department of Parasitology and Center of Excellence on Therapeutic Proteins and Antibody Engineering, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand;

关键词: Anti-hepatitis C virus (HCV) agent;    HCV protease;    homology modeling and molecular docking;    nanobody;    VHH;    phage display;    transbody;   

DOI  :  10.3390/v7042030

来源: DOAJ

【 摘 要 】

There is a need for safe and broadly effective anti-HCV agents that can cope with genetic multiplicity and mutations of the virus. In this study, humanized-camel VHHs to genotype 3a HCV serine protease were produced and were linked molecularly to a cell penetrating peptide, penetratin (PEN). Human hepatic (Huh7) cells transfected with theJFH-1 RNA of HCV genotype 2a and treated with the cell penetrable nanobodies (transbodies) had a marked reduction of the HCV RNA intracellularly and in theirculture fluids, less HCV foci inside the cells and less amounts of HCV core antigen inculture supernatants compared with the infected cells cultured in the medium alone. The PEN-VHH-treated-transfected cells also had up-regulation of the genes coding for thehost innate immune response (TRIF, TRAF3, IRF3, IL-28B and IFN-β), indicating thatthe cell penetrable nanobodies rescued the host innate immune response from the HCV mediated-suppression. Computerized intermolecular docking revealed that the VHHs bound to residues of the protease catalytic triad, oxyanion loop and/or the NS3 N-terminal portion important for non-covalent binding of the NS4A protease cofactor protein. The so-produced transbodies have high potential for testing further as a candidate for safe, broadly effective and virus mutation tolerable anti-HCV agents.

【 授权许可】

Unknown